RAQUEL GUEVARRA: Open Payments
NPI 1366942229 · HUNTINGTON PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 19 payments from 8 companies in 2025. Trend: 2023 $465 · 2024 $1,199 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Cranial Technologies, Inc | 8 | $142 |
| Regeneron Healthcare Solutions, Inc. | 3 | $91 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| GENZYME CORPORATION | 1 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Cipher Pharmaceuticals US LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Doc Band, DUPIXENT, MOUNJARO, Natroba, M-M-R II, CAPVAXIVE, GARDASIL 9, Wegovy.
Industry payments across CA — which companies pay providers there.
